ASTEPRO 0.15%—the Earlier the Better
- Provides rapid relief in as early as 30 to 45 minutes1,2*
- Symptom relief right at the site
- Treats nasal symptoms, including congestion, without an added decongestant3,4
- Indicated for seasonal and perennial allergic rhinitis3
- ASTEPRO 0.15% has no generic equivalent
- Contains 50% higher concentration per spray than azelastine HCI 0.1% - ASTEPRO 0.15% provides trial samples that last 3–5 days
- 1 Rx;
- 1 Copay;
- Nearly 2 Months of Therapy
Allergy Advisor
For Physicians
The Earlier the Better—30 to 45 minute onset of action
For Pharmacists
Highest Tier 2 availability
For Patients
Read more about ASTEPRO 0.15% and the allergy symptom relief it delivers
*In 2 placebo-controlled SAR studies (N=1143), ASTEPRO 0.15% (2 sprays per nostril) relieved rhinitis symptoms in as early as 30 to 45 minutes, and the effect remained durable over the 4-hour assessment period.
Indication
ASTEPRO® (azelastine HCl) Nasal Spray 0.15% is indicated for the relief of the symptoms of seasonal and perennial allergic rhinitis in patients 12 years of age and older.
Important Risk Information
- Avoid engaging in hazardous occupations requiring complete mental alertness when taking ASTEPRO Nasal Spray 0.15%
- Avoid concurrent use of alcohol or other central nervous system depressants with ASTEPRO Nasal Spray 0.15%
- In clinical studies, the most commonly reported adverse reactions, when dosed at 2 sprays per nostril once or twice daily, respectively, included bitter taste (4%, 6%), nasal discomfort (4%, 3%), epistaxis (2%, 1%), and sneezing (1%, 2%)
- Pregnancy Category C: Based on animal data, may cause fetal harm
Please see full Prescribing Information
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1‐800‐FDA‐1088